NO880851L - Fremgangsmaate for fremstilling av nye renin-inhibitorer. - Google Patents

Fremgangsmaate for fremstilling av nye renin-inhibitorer.

Info

Publication number
NO880851L
NO880851L NO880851A NO880851A NO880851L NO 880851 L NO880851 L NO 880851L NO 880851 A NO880851 A NO 880851A NO 880851 A NO880851 A NO 880851A NO 880851 L NO880851 L NO 880851L
Authority
NO
Norway
Prior art keywords
group
lower alkyl
formula
rer
substituted
Prior art date
Application number
NO880851A
Other languages
English (en)
Norwegian (no)
Other versions
NO880851D0 (no
Inventor
Kohji Nakano
Takashi Fujikura
Ryuichiro Hara
Masato Ichiara
Yukiko Fukunaga
Masayuki Shibasaki
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Publication of NO880851D0 publication Critical patent/NO880851D0/no
Publication of NO880851L publication Critical patent/NO880851L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0227Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the (partial) peptide sequence -Phe-His-NH-(X)2-C(=0)-, e.g. Renin-inhibitors with n = 2 - 6; for n > 6 see C07K5/06 - C07K5/10
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06078Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/86Renin inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO880851A 1987-02-27 1988-02-26 Fremgangsmaate for fremstilling av nye renin-inhibitorer. NO880851L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP4645487 1987-02-27
JP11514487 1987-05-12
JP20614687 1987-08-18
JP28901787 1987-11-16

Publications (2)

Publication Number Publication Date
NO880851D0 NO880851D0 (no) 1988-02-26
NO880851L true NO880851L (no) 1988-08-29

Family

ID=27461876

Family Applications (1)

Application Number Title Priority Date Filing Date
NO880851A NO880851L (no) 1987-02-27 1988-02-26 Fremgangsmaate for fremstilling av nye renin-inhibitorer.

Country Status (6)

Country Link
US (1) US4904660A (fr)
EP (1) EP0281316A3 (fr)
AU (1) AU612626B2 (fr)
CA (1) CA1325497C (fr)
FI (1) FI89058C (fr)
NO (1) NO880851L (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0236734A3 (fr) * 1986-02-07 1988-05-11 Ciba-Geigy Ag Dérivés d'amino-5-hydroxy-4-valeryl substitués par des groupes contenant du soufre
EP0244083A3 (fr) * 1986-04-01 1989-11-15 Kissei Pharmaceutical Co. Ltd. Dérivés d'amino-acides
US4895834A (en) * 1986-12-15 1990-01-23 Warner-Lambert Company Renin inhibitors III
EP0326364B1 (fr) * 1988-01-26 1994-06-22 Sankyo Company Limited Polypeptide inhibant la rénine, sa fabrication et son utilisation
ZA897515B (en) * 1988-10-07 1990-06-27 Merrell Dow Pharma Novel peptidase inhibitors
US5736520A (en) * 1988-10-07 1998-04-07 Merrell Pharmaceuticals Inc. Peptidase inhibitors
CA2012306A1 (fr) * 1989-03-28 1990-09-28 Werner Neidhart Derives d'acides amines
US5098924A (en) * 1989-09-15 1992-03-24 E. R. Squibb & Sons, Inc. Diol sulfonamide and sulfinyl renin inhibitors
EP0427939A3 (en) * 1989-10-11 1991-11-06 American Cyanamid Company Renin inhibitors
TW225540B (fr) * 1990-06-28 1994-06-21 Shionogi & Co
AU1529997A (en) * 1996-01-16 1997-08-11 Warner-Lambert Company Substituted histidine inhibitors of protein farnesyltransferase

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52111572A (en) * 1976-03-16 1977-09-19 Santen Pharmaceutical Co Ltd Nn*mercapto substituted acyl**hystidine
AU1643283A (en) * 1982-07-19 1984-01-26 E.R. Squibb & Sons, Inc. Substituted peptides
JPS61236770A (ja) * 1985-04-15 1986-10-22 Kissei Pharmaceut Co Ltd 新規なアミノ酸誘導体
EP0244083A3 (fr) * 1986-04-01 1989-11-15 Kissei Pharmaceutical Co. Ltd. Dérivés d'amino-acides
US4921855A (en) * 1987-06-22 1990-05-01 Fujisawa Pharmaceutical Co., Ltd. New Histidyl amino acid derivatives, and pharmaceutical composition comprising the same

Also Published As

Publication number Publication date
AU1250288A (en) 1988-09-01
AU612626B2 (en) 1991-07-18
FI89058B (fi) 1993-04-30
FI880734A0 (fi) 1988-02-17
NO880851D0 (no) 1988-02-26
EP0281316A2 (fr) 1988-09-07
FI89058C (fi) 1993-08-10
CA1325497C (fr) 1993-12-21
FI880734L (fi) 1988-08-28
US4904660A (en) 1990-02-27
EP0281316A3 (fr) 1990-08-16

Similar Documents

Publication Publication Date Title
NO880851L (no) Fremgangsmaate for fremstilling av nye renin-inhibitorer.
NO914171L (no) Fremgangsmaate for fremstilling av peptidforbindelser
NO840551L (no) Fremgangsmaate ved fremstilling av terapeutisk virksomme 1,2,3,5-tetrahydroimidazo-(2,1-b)-kinazoliner
MY101541A (en) Indolizine derivatives, process for preparing them and the compositions containing them
HUP0001796A2 (hu) Dipeptid-benzamidinek mint kininogenáz inhibitorok, és a vegyületeket tartalmazó gyógyszerkészítmények
RU2004122926A (ru) Замещенные производные хиназолина как ингибиторы ауроракиназы
RU2006134002A (ru) Новые соединения, действующие как ингибиторы сериновой протеазы ns3 вируса гепатита с
EA200200333A1 (ru) Новый класс веществ, вызывающих дифференцировку клеток и являющихся ингибиторами гистондеацетилазы, и способы их применения
NO932813L (no) Peptider som er i stand til aa inhibere aktiviteten av HIV protease, deres fremstilling og deres terapeutiske anvendelse
BG100511A (en) Indole derivatives as nmda antagoniosts
RU96108920A (ru) Производные индола
KR920012082A (ko) Ace 억제제로서 유용한 신규 아미노 및 니트로 함유 삼환식 화합물
HUP0000894A2 (hu) Szubsztituált (1,3-bisz(ciklohexilmetil)-1,2,3,6-tetrahidro-2,6-dioxo-9H-purin-8-il)fenil-származékok és eljárás előállításukra
ATE491704T1 (de) 4-ä2-(cycloalkylamino)pyrimidin-4-ylü- (phenyl)imidazolin-2-onderivate als inhibitoren der p38-map-kinase zur behandlung von entzündlichen krankheiten
KR890004700A (ko) 포스포디에스테라제 억제제 및 트롬복산 a_2 길항제로 구성된 상승 작용성 배합물 이의 용도 및 이의 제조방법
ES8501412A1 (es) "un metodo para la preparacion de un derivado de aminoacido"
HUP0203275A2 (hu) 1-(Gyűrűs amino)-alkilciklohexán-származékok, ezeket tartalmazó görcsoldó hatású gyógyszerkészítmények, valamint ezek alkalmazása
WO1998053790A3 (fr) Composes pouvant inhiber le facteur de croissance de l'endothelium vasculaire pour l'empecher de se fixer a ses recepteurs
NO20054794L (no) 7 ([1, 4] dioksan-2-yl)-benzotiazolderivater som adenosinreseptorligander
PL241066A1 (en) Process for preparing novel derivatives of thiazole
EA199800470A1 (ru) Производные фосфоновой кислоты, обладающие ингибирующей активностью в отношении металлопептидаз
ES8702423A1 (es) Un procedimiento para la preparacion de tiazol y tiazin-ben-cimidazoles
RU96121821A (ru) Производные пурин-6-она, их таутомеры и соли, фармацевтическая композиция с воздействующей на уровень кгмп активностью
ES388561A1 (es) Procedimiento para la preparacion de compuestos derivados de aminoetanol.
GB1497734A (en) Diisocyanate polyaddition products